tiprankstipranks
Trending News
More News >
Atara Biotherapeutics (ATRA)
NASDAQ:ATRA
US Market

Atara Biotherapeutics (ATRA) Income Statement

Compare
1,168 Followers

Atara Biotherapeutics Income Statement

Last quarter (Q3 2025), Atara Biotherapeutics's total revenue was $3.45M, a decrease of -91.41% from the same quarter last year. In Q3, Atara Biotherapeutics's net income was $-4.30M. See Atara Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 128.94M$ 8.57M$ 63.57M$ 20.34M$ 0.00
Gross Profit
$ 107.93M$ -313.00K$ 63.57M$ -261.66M$ -244.65M
Operating Expenses
$ 191.37M$ 275.69M$ 344.09M$ 78.80M$ 64.40M
Depreciation and Amortization
$ 5.05M$ 4.83M$ 5.65M$ 9.35M$ 8.33M
EBITDA
$ -75.75M$ -266.00M$ -222.26M$ -331.12M$ -300.72M
Operating Income
$ -83.44M$ -276.01M$ -280.51M$ -340.46M$ -309.05M
Other Income/Expenses
$ -1.98M$ -105.00K$ 52.22M$ 367.00K$ 2.45M
Pretax Income
$ -85.42M$ -276.11M$ -228.29M$ -340.10M$ -306.61M
Net Income
$ -85.40M$ -276.13M$ -228.30M$ -340.14M$ -306.62M
Per Share Metrics
Basic EPS
$ -11.41$ -65.18$ -55.96$ -90.78$ -103.63
Diluted EPS
$ -11.41$ -65.18$ -55.96$ -90.78$ -103.63
Weighted Average Shares Outstanding
7.49M 4.24M 4.08M 3.75M 2.96M
Weighted Average Shares Outstanding (Diluted)
7.49M 4.24M 4.08M 3.75M 2.96M
Currency in USD

Atara Biotherapeutics Earnings and Revenue History